LRRK2 impairs autophagy by mediating phosphorylation of leucyl‐tRNA synthetase

Leucine‐rich repeat kinase 2 (LRRK2) is a causal gene of Parkinson disease. G2019S pathogenic mutation increases its kinase activity. LRRK2 regulates various phenotypes including autophagy, neurite outgrowth, and vesicle trafficking. Leucyl‐tRNA synthetase (LRS) attaches leucine to tRNALeu and activates mTORC1. Down‐regulation of LRS induces autophagy. We investigated the relationship between LRRK2 and LRS in regulating autophagy and observed interaction between endogenous LRRK2 and LRS proteins and LRS phosphorylation by LRRK2. Mutation studies implicated that T293 in the LRS editing domain was a putative phosphorylation site. Phospho‐Thr in LRS was increased in cells overexpressing G2019S and dopaminergic neurons differentiated from induced pluripotent stem (iPS) cells of a G2019S carrier. It was decreased by treatment with an LRRK2 kinase inhibitor (GSK2578215A). Phosphomimetic T293D displayed lower leucine bindings than wild type (WT), suggesting its defective editing function. Cellular expression of T293D increased expression of GRP78/BiP, LC3B‐II, and p62 proteins and number of LC3 puncta. Increase of GRP78 and phosphorylated LRS was diminished by treatment with GSK2578215A. Levels of LC3B, GRP78/BiP, p62, and α‐synuclein proteins were also increased in G2019S transgenic (TG) mice. These data suggest that LRRK2‐mediated LRS phosphorylation impairs autophagy by increasing protein misfolding and endoplasmic reticulum stress mediated by LRS editing defect.

• Publication year

  2018

• Venue

  Cell Biochemistry and Function

• Publication date

  2018-11-08

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1002/cbf.3364PMID 30411383
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Methionyl-tRNA-synthetase is a Novel Interacting Protein of LRRK2

  2018cited by this paper
• Familial knockin mutation of LRRK2 causes lysosomal dysfunction and accumulation of endogenous insoluble α-synuclein in neurons.

  2018cited by this paper
• Leucine-Rich Repeat Kinase 2 (LRRK2)

  2017cited by this paper
• Leucine-Rich Repeat Kinase (LRRK2) Genetics and Parkinson's Disease.

  2017cited by this paper
• Leucine-induced localization of Leucyl-tRNA synthetase in lysosome membrane.

  2017cited by this paper
• Distinctive genomic signature of neural and intestinal organoids from familial Parkinson's disease patient‐derived induced pluripotent stem cells

  2017cited by this paper
• LRRK2 Phosphorylation.

  2017cited by this paper
• The LRRK2–macroautophagy axis and its relevance to Parkinson's disease

  2017cited by this paper
• Clinical Features of LRRK2 Carriers with Parkinson's Disease.

  2017cited by this paper
• LRRK2 and Autophagy.

  2017cited by this paper
• LRRK2 at the interface of autophagosomes, endosomes and lysosomes

  2016cited by this paper
• ER stress and Parkinson's disease: Pathological inputs that converge into the secretory pathway.

  2016influential reference
• G2019S-LRRK2 Expression Augments α-Synuclein Sequestration into Inclusions in Neurons

  2016cited by this paper
• Progressive dopaminergic alterations and mitochondrial abnormalities in LRRK2 G2019S knock-in mice.

  2015cited by this paper
• Leucine-Rich Repeat Kinase 2 (LRRK2) phosphorylates p53 and induces p21WAF1/CIP1 expression

  2015influential reference
• Role of the unfolded protein response in the pathogenesis of Parkinson's disease.

  2015influential reference
• The complex relationships between microglia, alpha-synuclein, and LRRK2 in Parkinson's disease.

  2015cited by this paper
• Threonine 56 phosphorylation of Bcl-2 is required for LRRK2 G2019S-induced mitochondrial depolarization and autophagy.

  2015influential reference
• An early endosome regulator, Rab5b, is an LRRK2 kinase substrate.

  2015influential reference
• The physiological target for LeuRS translational quality control is norvaline

  2014cited by this paper
• Genetics and genomics of Parkinson’s disease

  2014cited by this paper
• The LRRK2 inhibitor GSK2578215A induces protective autophagy in SH-SY5Y cells: involvement of Drp-1-mediated mitochondrial fission and mitochondrial-derived ROS signaling

  2014cited by this paper
• Leucine‐rich repeat kinase 2 regulates Sec16A at ER exit sites to allow ER–Golgi export

  2014cited by this paper
• Lewy Body-like α-Synuclein Aggregates Resist Degradation and Impair Macroautophagy*♦

  2013cited by this paper
• Essential nontranslational functions of tRNA synthetases.

  2013cited by this paper
• GSK2578215A; a potent and highly selective 2-arylmethyloxy-5-substitutent-N-arylbenzamide LRRK2 kinase inhibitor.

  2012cited by this paper
• LRRK2 as a modulator of lysosomal calcium homeostasis with downstream effects on autophagy

  2012cited by this paper
• Leucyl-tRNA synthetase controls TORC1 via the EGO complex.

  2012cited by this paper
• Leucyl-tRNA synthetase is an intracellular leucine sensor for the mTORC1-signaling pathway.

  2012influential reference
• Dysregulated LRRK2 Signaling in Response to Endoplasmic Reticulum Stress Leads to Dopaminergic Neuron Degeneration in C. elegans

  2011cited by this paper
• Phosphorylation of glutamyl-prolyl tRNA synthetase by cyclin-dependent kinase 5 dictates transcript-selective translational control

  2011cited by this paper
• Dopaminergic Neuronal Loss, Reduced Neurite Complexity and Autophagic Abnormalities in Transgenic Mice Expressing G2019S Mutant LRRK2

  2011cited by this paper
• A more efficient method to generate integration-free human iPS cells

  2011cited by this paper
• Leucine-rich repeat kinase 2 regulates autophagy through a calcium-dependent pathway involving NAADP

  2011influential reference
• Biochemical and molecular features of LRRK2 and its pathophysiological roles in Parkinson's disease.

  2010cited by this paper
• Identification and Characterization of a Leucine-Rich Repeat Kinase 2 (LRRK2) Consensus Phosphorylation Motif

  2010cited by this paper
• SH-SY5Y human neuroblastoma cell line: in vitro cell model of dopaminergic neurons in Parkinson's disease.

  2010cited by this paper
• Caenorhabditits elegans LRK-1 and PINK-1 Act Antagonistically in Stress Response and Neurite Outgrowth*

  2009cited by this paper
• LRRK2 regulates autophagic activity and localizes to specific membrane microdomains in a novel human genomic reporter cellular model.

  2009cited by this paper
• Exogenous α-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells

  2009cited by this paper
• Role of autophagy in G2019S‐LRRK2‐associated neurite shortening in differentiated SH‐SY5Y cells

  2008influential reference
• Clearance and deposition of extracellular alpha-synuclein aggregates in microglia.

  2008cited by this paper
• LRRK2 regulates synaptic vesicle endocytosis.

  2008cited by this paper
• Identification of potential protein interactors of Lrrk2.

  2007cited by this paper
• Crystal structures of the editing domain of Escherichia coli leucyl-tRNA synthetase and its complexes with Met and Ile reveal a lock-and-key mechanism for amino acid discrimination.

  2006cited by this paper
• Crystal Structures of the CP1 Domain from Thermus thermophilus Isoleucyl-tRNA Synthetase and Its Complex with l-Valine*

  2004influential reference
• Structural and mechanistic basis of pre- and posttransfer editing by leucyl-tRNA synthetase.

  2003cited by this paper
• Macromolecular assemblage of aminoacyl-tRNA synthetases: quantitative analysis of protein-protein interactions and mechanism of complex assembly.

  2000cited by this paper
• Neuroprotection and Neuronal Differentiation Studies Using Substantia Nigra Dopaminergic Cells Derived from Transgenic Mouse Embryos

  1999cited by this paper
• Identification of the cis-Acting Endoplasmic Reticulum Stress Response Element Responsible for Transcriptional Induction of Mammalian Glucose-regulated Proteins

  1998cited by this paper
• Extra- and intracellular amino acid concentrations in continuous Chinese hamster ovary cell culture

  1994cited by this paper
• Alteration of aminoacyl-tRNA synthetase activities by phosphorylation with casein kinase I.

  1985influential reference

• Targeting the Interplay Between Autophagy and the Nrf2 Pathway in Parkinson’s Disease with Potential Therapeutic Implications

  2025cites this paper
• Depletion of tryptophanyl-tRNA synthetase and tryptophan accumulation triggers p53-dependent apoptosis

  2025cites this paper
• Exacerbated Cellular Senescence in Human Dopaminergic Neurons along with an Increase in LRRK2 Kinase Activity

  2025cites this paper
• Role of Cellular Senescence in Parkinson’s Disease: Potential for Disease-Modification Through Senotherapy

  2025cites this paper
• Autophagy Process in Parkinson's Disease Depends on Mutations in the GBA1 and LRRK2 Genes.

  2025cites this paper
• Autophagy Impairment in Parkinson’s Disease: Approaches to Therapy

  2025cites this paper
• The Multifaceted Role of LRRK2 in Parkinson’s Disease

  2025influential citation
• Cosmic kidney disease: an integrated pan-omic, physiological and morphological study into spaceflight-induced renal dysfunction

  2024cites this paper
• Comprehensive Analysis and Experimental Validation of the Parkinson’s Disease Lysosomal Gene ACP2 and Pan-cancer

  2024cites this paper
• Extracellular aaRSs drive autoimmune and inflammatory responses in rheumatoid arthritis via the release of cytokines and PAD4

  2023cites this paper
• Reprogramming iPSCs to study age-related diseases: Models, therapeutics, and clinical trials.

  2023cites this paper
• A metabolomics-based analysis of the metabolic pathways associated with the regulation of branched-chain amino acids in rats fed a high-fructose diet

  2023cites this paper
• LRRK2 phosphorylation status and kinase activity regulate (macro)autophagy in a Rab8a/Rab10-dependent manner

  2023cites this paper
• Deficiency of RAB39B Activates ER Stress-Induced Pro-apoptotic Pathway and Causes Mitochondrial Dysfunction and Oxidative Stress in Dopaminergic Neurons by Impairing Autophagy and Upregulating α-Synuclein

  2023cites this paper
• The multifaceted role of LRRK2 in Parkinson's disease: From human iPSC to organoids.

  2022cites this paper
• Human Induced Pluripotent Stem Cell Phenotyping and Preclinical Modeling of Familial Parkinson’s Disease

  2022cites this paper
• Lysosomal Pathogenesis of Parkinson’s Disease: Insights From LRRK2 and GBA1 Rodent Models

  2022cites this paper
• Frequency of Parkinson’s Disease Genes and Role of PARK2 in Amyotrophic Lateral Sclerosis: An NGS Study

  2022cites this paper
• Mitochondrial dysfunction promotes alternative gasdermin D-mediated inflammatory cell death and susceptibility to infection

  2021cites this paper
• Pasteurized non-fermented cow´s milk but not fermented milk is a promoter of mTORC1-driven aging and increased mortality.

  2021cites this paper
• LRRK2 at the Crossroad of Aging and Parkinson’s Disease

  2021cites this paper
• Targeting autophagy using small-molecule compounds to improve potential therapy of Parkinson's disease

  2021cites this paper
• The Cross-Links of Endoplasmic Reticulum Stress, Autophagy, and Neurodegeneration in Parkinson’s Disease

  2021cites this paper
• LRRK2 Kinase Inhibitor Rejuvenates Oxidative Stress-Induced Cellular Senescence in Neuronal Cells

  2021cites this paper
• Induced pluripotent stem cell derived from postmortem tissue in neurodegenerative disease research

  2021cites this paper
• Experimental studies of mitochondrial and lysosomal function in in vitro and in vivo models relevant to Parkinson's disease genetic risk.

  2020cites this paper
• Protein Kinase C Isozymes and Autophagy during Neurodegenerative Disease Progression

  2020cites this paper
• Human induced pluripotent stem cell models of neurodegenerative disorders for studying the biomedical implications of autophagy.

  2020cites this paper
• “LRRK2: Autophagy and Lysosomal Activity”

  2020cites this paper
• A Possible Modifying Effect of the G2019S Mutation in the LRRK2 Gene on GBA Parkinson's Disease

  2020cites this paper
• Proteostasis Disturbances and Inflammation in Neurodegenerative Diseases

  2020cites this paper
• LRRK2 and the Endolysosomal System in Parkinson’s Disease

  2020cites this paper
• The Role of iPSC Modeling Toward Projection of Autophagy Pathway in Disease Pathogenesis: Leader or Follower

  2020cites this paper
• Modeling Parkinson's Disease Using Induced Pluripotent Stem Cells

  2020cites this paper
• Progressive Supranuclear Palsy and Statin Use

  2020cites this paper
• Novel approaches to counter protein aggregation pathology in Parkinson's disease.

  2020cites this paper
• A Cleaning Crew: The Pursuit of Autophagy in Parkinson's Disease.

  2019cites this paper
• Dysfunction of Cellular Proteostasis in Parkinson’s Disease

  2019cites this paper
• Upregulation of the p53-p21 pathway by G2019S LRRK2 contributes to the cellular senescence and accumulation of α-synuclein

  2019cites this paper
• Induced pluripotent stem cell‐based modeling of mutant LRRK2‐associated Parkinson's disease

  2019influential citation
• Microglia depletion prior to lipopolysaccharide and paraquat treatment differentially modulates behavioral and neuronal outcomes in wild type and G2019S LRRK2 knock-in mice

  2019cites this paper
• Structural aspects of the regulation of Parkinson's Disease-associated LRRK2 Kinase by Rab GTPases

  2019cites this paper
• Autophagy and LRRK2 in the Aging Brain

  2019cites this paper
• Roles of aminoacyl-tRNA synthetases in immune regulation and immune diseases

  2019cites this paper
• The Vicious Cycle Between α‐Synuclein Aggregation and Autophagic‐Lysosomal Dysfunction

  2019cites this paper
• The Missing Heritability of Sporadic Frontotemporal Dementia: New Insights from Rare Variants in Neurodegenerative Candidate Genes

  2019cites this paper
• Rab GTPases as Physiological Substrates of LRRK2 Kinase

  2019cites this paper